Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 179,018 | 483,311 | 302,785 | 314,850 | 363,678 |
| Marketable Securities | 266,862 | 258,064 | 458,762 | 521,109 | 483,906 |
| Receivables | 237,572 | 209,280 | 201,368 | 198,524 | 1,133 |
| Inventories | 246,369 | 232,765 | 311,395 | 496,349 | 38,532 |
| Income taxes - deferred | 131,980 | 133,715 | 118,931 | 123,945 | 24,872 |
| Other current assets | 202,434 | 190,465 | 174,923 | 183,887 | 112,680 |
| TOTAL | $1,264,235 | $1,507,600 | $1,568,164 | $1,838,664 | $1,046,911 |
| Non-Current Assets | |||||
| PPE Net | 1,415,689 | 1,354,016 | 1,297,862 | 1,252,783 | 444,207 |
| Investments And Advances | 1,818,945 | 1,736,621 | 1,936,881 | 1,622,620 | 656,771 |
| Intangibles | 4,521,729 | 4,629,105 | 4,708,696 | 4,789,878 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 92,006 |
| TOTAL | $7,756,363 | $7,719,742 | $7,943,439 | $7,665,281 | $1,192,984 |
| Total Assets | $9,020,598 | $9,227,342 | $9,511,603 | $9,503,945 | $2,239,895 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 77,493 | 85,817 | 78,382 | 63,364 | 65,716 |
| Accrued Expenses | 197,777 | 181,514 | 183,479 | 240,130 | N/A |
| Other current liabilities | N/A | N/A | N/A | N/A | 731 |
| TOTAL | $428,601 | $396,636 | $362,834 | $404,825 | $66,447 |
| Non-Current Liabilities | |||||
| Long Term Debt | 845,704 | 866,229 | 861,293 | 887,270 | 881,956 |
| Deferred Revenues | 14,955 | 6,479 | 6,038 | 7,155 | N/A |
| aiOther Non-Current Liabilities | 50,359 | 52,210 | 51,937 | 50,204 | 29,548 |
| TOTAL | $1,881,735 | $1,896,539 | $1,951,288 | $2,045,792 | $911,504 |
| Total Liabilities | $2,310,336 | $2,293,175 | $2,314,122 | $2,450,617 | $977,951 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 333,552 | 338,393 | 339,759 | 331,997 | 155,673 |
| Common Shares | 173 | 171 | 171 | 166 | 79 |
| Retained earnings | -744,499 | -725,516 | -653,116 | -611,921 | 378,642 |
| Other shareholders' equity | -44,674 | -62,880 | -43,934 | -1,087 | 2,189 |
| TOTAL | $6,710,262 | $6,934,167 | $7,197,481 | $7,053,328 | $1,261,944 |
| Total Liabilities And Equity | $9,020,598 | $9,227,342 | $9,511,603 | $9,503,945 | $2,239,895 |